46

Logo

Rius Medical

Company | Waldachtal, Germany
5

followers

Primary tabs

About your organization

The Elevator Pitch: Rius Medical is developing Advanced Manufacturing to help patients with cancer and other diseases, like type 1 diabetes by solving the problem of Drug Delivery through reprogramming stem cells.

On offer as Business-to-Business solution to France-based Erytech Pharma, Switzerland-based Orphan Technologies among others is upgraded red blood cells that do more than simply carry oxygen. For example Erytech Pharma’s therapeutic product (half-life 29 days) is undergoing clinical Phase III for pancreatic cancer and clinical Phase II for breast cancer. The Business Model is that of a provider/supplier of 120 days lifespan red blood cells against blood donation half-life 29 days red blood cells.

Rius Medical is seeking a 400,000 euro bridge financing for early start July 2023 onwards – supporting the exploration of bold ideas for radically new technologies. Rius Medical proposal has a convincing long-term vision of a radically new technology with a transformative positive effect to the economy and society.

An EXIT opportunity at year 2 for early investors joining this Series A investment round of up to 1 million euro and post-money valuation at 5 million euro will result in EUR 10,5 million financial benefits on TWO products at year 2. So 400,000 euro bridge financing against 8% ownership results in EUR 4,2 million financial benefits on TWO products by December 2024!

News

Equity investor for 30.000 euro

Type of partnership
Ask
Scope of the partnership
Technological

Network (0)

There are no organizations in the network.

Recent activity

You are not connected

A certain number of contents are hidden from you and you do not benefit from the linking functionalities.

Log in or register to access to the entire contents and functionnalities. Subscription is quick and free.